癫痫
医学
病理
CD8型
自身免疫性肝炎
免疫学
癌症研究
细胞生物学
肝炎
抗原
生物
疾病
罗赛-多夫曼病
作者
Ju Bo Liang,Yong Chen,Rui Ling Chen,Yi Kang Li,Bo Li,You Zheng,You Li,Jun Zhang,Bing Huang,Yi Wei,Zhu Wan Lyu,Min Lian,Xiao Xiao,Qi Xia Wang,Ru Tang,Jing‐Yuan Fang,Xiao Yu Chen,Xiong Ma,Qi Miao
标识
DOI:10.1111/1751-2980.12995
摘要
Objective Emperipolesis is a pathological feature for the diagnosis of autoimmune hepatitis (AIH). We have previously found that CD8 + T cells participated in the emperipolesis in AIH. In this study we aimed to clarify the characteristics and molecular mechanisms of emperipolesis in patients with AIH in vitro and in mice with α‐Galactosylceramide (α‐GalCer)‐induced acute hepatitis. Methods The peripheral blood mononuclear cells (PBMC) of patients with various chronic liver diseases and healthy controls were co‐cultured with hepatic cell lines to induce emperipolesis in vitro. Confocal staining was performed to illustrate the cellular types and potential mechanisms of emperipolesis in AIH. In addition, a murine model of α‐GalCer‐induced acute hepatitis that mimics human AIH was used to confirm the role of CD44/p‐ERM/F‐actin in the emperipolesis process in vivo. Results In the co‐cultured system of PBMC and hepatic cell line, emperipolesis was observed most commonly in patients with AIH. The main cells participating in emperipolesis were CD8 + T cells, and they penetrated hepatic cells actively via the CD44/p‐ERM/F‐actin pathway. As a result, most CD8 + T cells engulfed by hepatic cells underwent apoptosis. In the α‐GalCer‐induced acute hepatitis model, emperipolesis was observed around the inflammatory foci and was inhibited by the ezrin phosphorylation inhibitor NSC668394. Similarly, activated murine CD8 + T cells penetrated primary hepatocytes via the CD44/p‐ERM/F‐actin pathway in vitro. Conclusions CD8 + T cells penetrate hepatic cells actively via the CD44/p‐ERM/F‐actin signaling pathway and undergo apoptosis. This may be a compensatory mechanism to attenuate the overwhelming immune attack in AIH.
科研通智能强力驱动
Strongly Powered by AbleSci AI